ASAP News

The FMCSA announced new updates to its Compliance Safety Accountability (CSA) enforcement program.  The goal is to more quickly identify and address the “high-risk” truck and bus companies with compliance concerns.  The changes to be implemented in December 2012 are […]

This year, the Annual World EAP Conference sponsored by the Employee Assistance Professional Association (EAPA) will be held in Baltimore, MD on October 17-20th.  ASAP is a proud Silver sponsor at this year’s conference and will exhibit at booth #220. 

Smiles or 2C-I is one of the latest synthetic drugs that has gained popularity and has been associated with the recent deaths of two teens in North Dakota.  The synthetic drug which has no approved medical use in the US

For nearly 28 years, American Substance Abuse Professionals has made its home in the historic Hampden neighborhood of Baltimore, MD.  With the change of the season, the time has also come for ASAP to make a change.  The company is

In their most recent newsletter the Federal Transit Administration (FTA) offered clarification regarding  a “refusal to test” on a pre-employment drug screen.  The article stated thatall persons applying for or being transferred to a safety sensitive position under the FTA

ASAP CEO Reed Morrison, Ph.D. was a participating panelist on the SAE Panel Discussion presented to the Nuclear Energy Institute’s Access Authorization and Fitness-for Duty Workshop.  The workshop is an annual event that was held this year in Miami, FL,

The National Highway Traffic Safety Administration (NHTSA) recently amended the Conforming Products List (CPL) for two types of alcohol testing devices. In June 2012, the NHTSA updated the CPL for instruments that conform to the Model Specifications for Screening Devices

In June 25 ASAP welcomed guest speaker Dr. Kristine Hitchens.  Dr. Hitchens presented on the impact of substance abuse on the family.  With extensive experience in the field of substance abuse and social work, Dr. Hitchens delivered first-hand accounts of

The Federal Aviation Administration (FAA) issued a notice of proposed rulemaking on July 2, 2012.    According to the Federal Register, “This rulemaking would allow air carrier operators and commuter or on-demand operators that also conduct commercial air tour operations to

Addressing the threat of synthetic drugs, the US Congress passed the Synthetic Drug Abuse Prevention Act of 2012.  It is part of the larger Food and Drug Administration Safety and Innovation Act. The act classifies synthetic drugs as Schedule 1